Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy

firstwordpharmaDecember 04, 2018

Tag: SRK-015 , Spinal Muscular Atrophy , Orphan Drug , SRK-015

PharmaSources Customer Service